1. Home /
  2. Investing /
  3. Cannabis


Village Farms Plays Chess While Traders Play Checkers

The shelf offering isn't a risk. Not having access to it was.

CBD Is Flexing on the Marijuana Industry

Be sure your cannabis investments have the right CBD strategy, as the market for these products takes off.

Market Climbing a Wall of Worry

This is a bullish market that -- rather than celebrating a dovish Fed and new highs -- fears missing out.

CannTrust Is Caught in a Cannabis Catch-22

The loss of clients is a primary concern here.

Cronos Group Could Break Key Moving Averages - Protect Long Positions

Let's look at the chart of CRON.

Here's Why I'm Willing to Play Village Farms Stock

The business continues to churn forward as the company announced it has achieved a full run-rate production of 75K kg at its Delta 3 greenhouse.

These 2 Stocks Remain the Favorites of Top Newsletter Advisors

A cannabis-related REIT soared 172% in the first half of the year while a cloud services provider was up 53%, with more gains expected.

Morningstar High on Pot Growth, Sees U.S. Going Legal by 2023

Analysts say nation will turn a new leaf, changing federal law within a few years, as cannabis industry expected to grow big time over next decade.

The Greenhouse Effect: Village Farms Takes Aim at Hemp and CBD Opportunities

CEO MIke DeGiglio on the company's long history as a greenhouse grower, its biggest opportunities, Canadian joint venture Pure Sunfarms, and its footprint in one the best growing climates in the U.S. for cannabis.

Constellation Brands Is Looking Better but I Have a Fear of Commitment

Let's examine the latest charts and indicators.

Terra Tech Is Riding the Cannabis Wave

CEO Derek Peterson on how a surfing accident led to the company's founding, being the first plant-touching company to go public, competition and the next big cannabis opportunity.

Cannabis Q&A: Get to Know Colorado-Based GrowCentria

This natural and organic cultivation inputs company has the leading biological brand in the market - Mammoth.

OrganiGram Could Climb Higher, but You Need Discipline Before Buying

Here's how to play OGI stock right now.

Green Growth Brands Could Be at a Level to Probe the Long Side

Let's take a look at the charts.

Cannabis Q&A: Greenlane's IPO Gives It the Green Light for Growth

Recently public company is the leading distributor of premium vaporization products and consumption accessories in the U.S.

Canaccord Raises Outlook for Cannabis Growth in the U.S.

Still, the firm rates the companies mentioned as speculative buys.

Constellation Brands Is Flexing Its Beer Muscles - And Upside Potential

Management's disappointment in Canopy Growth is akin to a coach expressing his displeasure with a prized rookie.

Constellation Brands Could Trade Sideways - Watch the OBV Line for Bullish Clues

Let's see if we can identify the next sustained move.

Cannabis Q&A: Elixinol Is a Hemp/CBD Player You Should Know About

It is important to expand your understanding beyond a few companies or a single concept.

Constellation Brands Remains Beer Dependent as it Transforms Itself

Changes will come as they move their wine and spirits business to the 'high end', and develop the activities of Canopy Growth, which promises cannabis-infused drinks.

5 Cannabis ETFs to Fire Up Your Portfolio

Two of them are brand new.

Prohibition and the Paradoxical Proclivity of Cannabis Consumption

Is prohibition the real factor propping up projections for demand and pricing in the cannabis market?

Not High on Canopy Growth's Earnings? Take a Deeper Look

At first glance, CGC's report looks like a drag, but you must dig into the weeds to see how timing and the industry are at play.

At Canopy Growth it's a Question of Expansion vs. Value

Canopy Growth's latest financial results offer a reality check.

Should Investors Buy the Dip in Canopy Growth Stock?

Canopy's earnings losses could just be a stepping stone to becoming the industry leader.

Canopy Growth's Latest Results Can Be Wrapped Up in One Word: Ugly

The cannabis company's performance as outlined in its year-end report should not inspire investor confidence.

Canopy Growth Slips as Production, Margins Disappoint

While the cannabis company's stock is sliding on its year-end report, at least one analyst sees a long-term buying opportunity.

Beyond Meat Went Beyond Logic, and Now It's Beyond Trading

There's no way to play the stock of the meat alternative provider unless you are a kamikaze daredevil with a very deep pocketbook.

Convenience Stores Want to Radically Change the Cannabis Industry

If cannabis is descheduled, it is likely it will become federally regulated -- and convenience stores are preparing their case for selling it like tobacco products.

Cannabis Update: Canopy Growth and Acreage Holdings

Let's look at the charts this morning.